Pharmacologic management of pain in patients with Chikungunya: a guideline
Abstract From the arrival of Chikungunya virus in the Americas in 2013 until March 2016, approximately two million cases of the disease have been reported. In Brazil, the virus was identified in 2014 and thousands of people have been affected. The disease has high attack rates, infecting 50% of a po...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Medicina Tropical (SBMT)
|
Series: | Revista da Sociedade Brasileira de Medicina Tropical |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822016000600668&lng=en&tlng=en |
id |
doaj-e6508ba01f2b47f0bb582980694e9503 |
---|---|
record_format |
Article |
spelling |
doaj-e6508ba01f2b47f0bb582980694e95032020-11-24T22:46:46ZengSociedade Brasileira de Medicina Tropical (SBMT)Revista da Sociedade Brasileira de Medicina Tropical1678-984949666867910.1590/0037-8682-0279-2016S0037-86822016000600668Pharmacologic management of pain in patients with Chikungunya: a guidelineCarlos Alexandre Antunes de BritoAna Karla Arraes von SohstenClezio Cordeiro de Sá LeitãoRita de Cássia Coelho Moraes de BritoLilian David De Azevedo ValadaresCaroline Araújo Magnata da FonteZelina Barbosa de MesquitaRivaldo Venâncio CunhaKleber LuzHelena Maria Carneiro LeãoCecília Moraes de BritoLívia Carla Vinhal FrutuosoAbstract From the arrival of Chikungunya virus in the Americas in 2013 until March 2016, approximately two million cases of the disease have been reported. In Brazil, the virus was identified in 2014 and thousands of people have been affected. The disease has high attack rates, infecting 50% of a population within a few months. Approximately 50% of infected people develop chronic symptoms lasting for months or years. Joint involvement is the main clinical manifestation of Chikungunya. It is characterized by swelling and intense pain that is poorly responsive to analgesics, both in the acute and chronic phase of the disease. This significantly compromises quality of life and may have immeasurable psychosocial and economic repercussions, constituting therefore, a serious public health problem requiring a targeted approach. Physicians are often not familiar with how to approach the management of pain, frequently prescribing limited analgesics, such as dipyrone, in sub-therapeutic doses. In addition, there are few published studies or guidelines on the approach to the treatment of pain in patients with Chikungunya. Some groups of specialists from different fields have thus developed a protocol for the pharmacologic treatment of Chikungunya-associated acute and chronic joint pain; this will be presented in this review.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822016000600668&lng=en&tlng=enChikungunyaPainArthralgiaArbovirusTreatment |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Carlos Alexandre Antunes de Brito Ana Karla Arraes von Sohsten Clezio Cordeiro de Sá Leitão Rita de Cássia Coelho Moraes de Brito Lilian David De Azevedo Valadares Caroline Araújo Magnata da Fonte Zelina Barbosa de Mesquita Rivaldo Venâncio Cunha Kleber Luz Helena Maria Carneiro Leão Cecília Moraes de Brito Lívia Carla Vinhal Frutuoso |
spellingShingle |
Carlos Alexandre Antunes de Brito Ana Karla Arraes von Sohsten Clezio Cordeiro de Sá Leitão Rita de Cássia Coelho Moraes de Brito Lilian David De Azevedo Valadares Caroline Araújo Magnata da Fonte Zelina Barbosa de Mesquita Rivaldo Venâncio Cunha Kleber Luz Helena Maria Carneiro Leão Cecília Moraes de Brito Lívia Carla Vinhal Frutuoso Pharmacologic management of pain in patients with Chikungunya: a guideline Revista da Sociedade Brasileira de Medicina Tropical Chikungunya Pain Arthralgia Arbovirus Treatment |
author_facet |
Carlos Alexandre Antunes de Brito Ana Karla Arraes von Sohsten Clezio Cordeiro de Sá Leitão Rita de Cássia Coelho Moraes de Brito Lilian David De Azevedo Valadares Caroline Araújo Magnata da Fonte Zelina Barbosa de Mesquita Rivaldo Venâncio Cunha Kleber Luz Helena Maria Carneiro Leão Cecília Moraes de Brito Lívia Carla Vinhal Frutuoso |
author_sort |
Carlos Alexandre Antunes de Brito |
title |
Pharmacologic management of pain in patients with Chikungunya: a guideline |
title_short |
Pharmacologic management of pain in patients with Chikungunya: a guideline |
title_full |
Pharmacologic management of pain in patients with Chikungunya: a guideline |
title_fullStr |
Pharmacologic management of pain in patients with Chikungunya: a guideline |
title_full_unstemmed |
Pharmacologic management of pain in patients with Chikungunya: a guideline |
title_sort |
pharmacologic management of pain in patients with chikungunya: a guideline |
publisher |
Sociedade Brasileira de Medicina Tropical (SBMT) |
series |
Revista da Sociedade Brasileira de Medicina Tropical |
issn |
1678-9849 |
description |
Abstract From the arrival of Chikungunya virus in the Americas in 2013 until March 2016, approximately two million cases of the disease have been reported. In Brazil, the virus was identified in 2014 and thousands of people have been affected. The disease has high attack rates, infecting 50% of a population within a few months. Approximately 50% of infected people develop chronic symptoms lasting for months or years. Joint involvement is the main clinical manifestation of Chikungunya. It is characterized by swelling and intense pain that is poorly responsive to analgesics, both in the acute and chronic phase of the disease. This significantly compromises quality of life and may have immeasurable psychosocial and economic repercussions, constituting therefore, a serious public health problem requiring a targeted approach. Physicians are often not familiar with how to approach the management of pain, frequently prescribing limited analgesics, such as dipyrone, in sub-therapeutic doses. In addition, there are few published studies or guidelines on the approach to the treatment of pain in patients with Chikungunya. Some groups of specialists from different fields have thus developed a protocol for the pharmacologic treatment of Chikungunya-associated acute and chronic joint pain; this will be presented in this review. |
topic |
Chikungunya Pain Arthralgia Arbovirus Treatment |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822016000600668&lng=en&tlng=en |
work_keys_str_mv |
AT carlosalexandreantunesdebrito pharmacologicmanagementofpaininpatientswithchikungunyaaguideline AT anakarlaarraesvonsohsten pharmacologicmanagementofpaininpatientswithchikungunyaaguideline AT cleziocordeirodesaleitao pharmacologicmanagementofpaininpatientswithchikungunyaaguideline AT ritadecassiacoelhomoraesdebrito pharmacologicmanagementofpaininpatientswithchikungunyaaguideline AT liliandaviddeazevedovaladares pharmacologicmanagementofpaininpatientswithchikungunyaaguideline AT carolinearaujomagnatadafonte pharmacologicmanagementofpaininpatientswithchikungunyaaguideline AT zelinabarbosademesquita pharmacologicmanagementofpaininpatientswithchikungunyaaguideline AT rivaldovenanciocunha pharmacologicmanagementofpaininpatientswithchikungunyaaguideline AT kleberluz pharmacologicmanagementofpaininpatientswithchikungunyaaguideline AT helenamariacarneiroleao pharmacologicmanagementofpaininpatientswithchikungunyaaguideline AT ceciliamoraesdebrito pharmacologicmanagementofpaininpatientswithchikungunyaaguideline AT liviacarlavinhalfrutuoso pharmacologicmanagementofpaininpatientswithchikungunyaaguideline |
_version_ |
1725683883041619968 |